Prosecution Insights
Prosecution Insights
Tech Center 3900 • Art Units: 1611 1658 3991
This examiner grants 25% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16120549 | GROWTH DIFFERENTIATION FACTOR 11 (GDF-11) FOR TREATMENT OF DIASTOLIC HEART FAILURE | Non-Final OA | President and Fellows of Harvard College |
| 18320145 | TUMOR-SPECIFIC MINICIRCLES FOR CANCER SCREENING | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18711216 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A TETRA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES | Non-Final OA | Merck Sharp & Dohme LLC |
| 18662935 | COMBINATIONS AND METHODS FOR SUBCUTANEOUS ADMINISTRATION OF IMMUNE GLOBULIN AND HYALURONIDASE | Non-Final OA | Takeda Pharmaceutical Company Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy